China Medical Technologies (中国医疗技术公司) has received approval from the SFDA for two new FISH probes: the Prenatal FISH Probe and Cervical Cancer FISH Probe. The Prenatal FISH Probe is a detection kit for the analysis of trisomies 13, 18 and 21 (Down Syndrome) and sex chromosome aneusomies (X and Y). The Cervical Cancer FISH Probe seeks to detect the amplification of the TERC gene in human cervical tissue. More details...

Stock Symbol: (NSDQ: CMED)